2013 - International Conference on Transplantomics and Biomarkers in Organ Transplantation


Plenary 6: Long-Term Graft Acceptance

7.3 - Accommodation

Presenter: Tony, Dorling, , United Kingdom
Authors: Tony Dorling


Overview:

‘Accommodation’ refers to a vascularized transplant that has acquired resistance to antibody-mediated rejection. The phenomenon was first described after clinical ABO-incompatible (ABOi) renal transplantation in the 1980s and is recognised as a common outcome in this context today. Platt and Bach defined three potential mechanisms to explain accommodation, of which the development of endothelial cell cytoprotection is the most studied. Although much is known about how accommodation arises in animal models and there are reliable ways to induce it, little is known about how it arises after clinical ABOi transplantation, there is no way to induce it clinically and most importantly there is no dependable way of recognising when it has occurred. In this talk, I will review recent progress in this area and highlight how accommodation could be of benefit, alongside other strategies, to prolong the life of human transplanted organs.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi